ProShares Ultra Nasdaq Biotechnology BIB
120.00 USD -3.13 (-2.54%)
Nov 12, 2026, 9:38 AM EST
120.02 Day range 120.02
73.12 52-week range 126.40
- YTD
- +50.41%
- 1 year
- +57.75%
Benzinga news
benzinga.com Man in Germany Cured of HIV After Undergoing Stem Cell Transplant, According to Report in Nature Medicine https://www.dailymail.co.uk/health/article-11772327/Man-CURED-HIV-D-sseldorf-patient-virus-free.html?ito=social-twitter_mailonline https://www.nature.com/articles/s41591-023-02213-x
benzinga.com Psychedelics Company COMPASS Pathways To Join NASDAQ Biotechnology Index Psilocybin-focused mental health care company COMPASS Pathways plc (NASDAQ: CMPS) revealed Friday that it has been selected for addition to the Nasdaq Biotechnology Index (NASDAQ: NBI), effective as…- benzinga.com Exclusive: SunTrust Managing Director Discusses Bluebird Bio, A Leader In Gene Therapy
- benzinga.com Biotechs Are Ripping Following IPAB Ruling
benzinga.com New Study Suggests Drug Prices Have Doubled Since 2011: What's It Mean For The Market? 
benzinga.com ProShares Releases 2 New Leveraged Biotech ETFs 
benzinga.com Why Investors Should Closely Watch Celgene - benzinga.com UCB Sales Rise in Q1 - Analyst Blog
- benzinga.com Seven ETFs On A Roll (BIB, SOCL, TAN)
- benzinga.com If Stocks Keep Soaring, Get to Know These Leveraged ETFs
benzinga.com ProShares to Split 2, Reverse Split 9 ETFs - benzinga.com Low Volume, High Returns for These ETFs (BIB, FHC, DRW)
- benzinga.com Nine ETFs on a Roll (DRN, TQQQ, BIB, BGU)